|
US3152148A
(en)
|
1963-01-03 |
1964-10-06 |
Dow Chemical Co |
Preparation of comenic and pyromeconic acids
|
|
US3441605A
(en)
|
1965-02-17 |
1969-04-29 |
Wallace & Tiernan Inc |
Diketo-dicarboxylic acids and salts and preparation thereof by alkaline oxidation
|
|
FR1545224A
(fr)
|
1966-12-21 |
1968-11-08 |
Geigy Ag J R |
Procédé de préparation de l'acide sébacique
|
|
GB1196595A
(en)
|
1966-12-21 |
1970-07-01 |
Geigy Uk Ltd |
Preparation of a Lactone
|
|
GB1196598A
(en)
|
1966-12-21 |
1970-07-01 |
Geigy Uk Ltd |
Preparation of a Ketosebacic Acid
|
|
GB1196597A
(en)
|
1966-12-21 |
1970-07-01 |
Geigy Uk Ltd |
Preparation of an Oxido-Cyclodecene
|
|
GB1196596A
(en)
|
1966-12-21 |
1970-07-01 |
Geigy Uk Ltd |
Preparation of a hydroxysebacic acid
|
|
GB1196594A
(en)
|
1966-12-21 |
1970-07-01 |
Geigy Uk Ltd |
Improvements in and relating to the production of Sebacic Acid
|
|
US3930024A
(en)
|
1969-09-02 |
1975-12-30 |
Parke Davis & Co |
Pharmaceutical compositions and methods
|
|
US3773946A
(en)
|
1969-09-02 |
1973-11-20 |
Parke Davis & Co |
Triglyceride-lowering compositions and methods
|
|
JPS5522636A
(en)
|
1978-08-04 |
1980-02-18 |
Takeda Chem Ind Ltd |
Thiazoliding derivative
|
|
US4281200A
(en)
|
1979-08-30 |
1981-07-28 |
The Dow Chemical Company |
Catalytic process for converting oxazolidinones to their corresponding aminoalcohols
|
|
JPS5639033A
(en)
|
1979-09-04 |
1981-04-14 |
Kao Corp |
Alpha-mono(methyl-branched alkyl glyceryl ether and skin cosmetic containing the same
|
|
IL64542A0
(en)
|
1981-12-15 |
1982-03-31 |
Yissum Res Dev Co |
Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
|
IT1164254B
(it)
|
1983-05-30 |
1987-04-08 |
Luso Farmaco Inst |
3-(3-idrossibutossi)-1-butanolo e suo metodo di preparazione
|
|
JPS59232811A
(ja)
|
1983-06-16 |
1984-12-27 |
Sumitomo Chem Co Ltd |
芳香族ポリアミドイミド樹脂成形体の製造方法
|
|
JPS60136512A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
脂質代謝改善剤
|
|
DE3423166A1
(de)
|
1984-06-22 |
1986-01-02 |
Epis S.A., Zug |
Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
|
US4896344A
(en)
|
1984-10-15 |
1990-01-23 |
Grady John K |
X-ray video system
|
|
US4634119A
(en)
|
1985-07-11 |
1987-01-06 |
Pesthy Paul K |
Resilient exercise machine with body support platform
|
|
US4714762A
(en)
|
1986-10-31 |
1987-12-22 |
Warner-Lambert Company |
Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof
|
|
US5166174A
(en)
|
1987-01-28 |
1992-11-24 |
K.K. Ueno Seiyaku Oyo Kenkyujo |
Prostaglandins E and anti-ulcers containing same
|
|
US5225439A
(en)
|
1987-01-28 |
1993-07-06 |
K.K. Ueno Seiyaku Oyo Kenkyujo |
Prostaglandins E and anti ulcers containing same
|
|
US5428062A
(en)
|
1987-01-28 |
1995-06-27 |
K.K. Ueno Seiyaku Oyo Kenkyujo |
Prostaglandins E and anti ulcers containing same
|
|
US4758880A
(en)
|
1987-03-27 |
1988-07-19 |
The Grass Valley Group, Inc. |
Video matte generator
|
|
JP2999579B2
(ja)
|
1990-07-18 |
2000-01-17 |
武田薬品工業株式会社 |
Ｄｎａおよびその用途
|
|
US5254589A
(en)
|
1991-10-15 |
1993-10-19 |
Warner-Lambert Company |
Sulfonyl urea and carbamate ACAT inhibitors
|
|
IL109431A
(en)
|
1993-05-14 |
2001-01-11 |
Warner Lambert Co |
Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
|
|
US5420339A
(en)
|
1993-11-22 |
1995-05-30 |
Warner-Lambert Company |
Alpha-aryl or heteroaryl-substituted amide ester ACAT inhibitors
|
|
JP2937012B2
(ja)
|
1994-04-08 |
1999-08-23 |
時久 増田 |
角筒包装袋の製造方法及び装置
|
|
US5578639A
(en)
|
1994-07-01 |
1996-11-26 |
Warner-Lambert Company |
PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
|
|
US5504073A
(en)
|
1994-07-01 |
1996-04-02 |
Warner-Lambert Company |
PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
|
|
SE9500778D0
(sv)
|
1995-03-03 |
1995-03-03 |
Pharmacia Ab |
Process for producing a protein
|
|
US5648387A
(en)
|
1995-03-24 |
1997-07-15 |
Warner-Lambert Company |
Carboxyalkylethers, formulations, and treatment of vascular diseases
|
|
WO1997016184A1
(en)
|
1995-11-02 |
1997-05-09 |
Warner-Lambert Company |
Method and pharmaceutical composition for regulating lipid concentration
|
|
JP4139448B2
(ja)
|
1996-08-13 |
2008-08-27 |
信越化学工業株式会社 |
α−ブロモ，ω−クロロアルカンの製造方法
|
|
US5807846A
(en)
|
1996-11-14 |
1998-09-15 |
Warner-Lambert Company |
Phosphonamide ACAT inhibitors
|
|
IL119971A
(en)
|
1997-01-07 |
2003-02-12 |
Yissum Res Dev Co |
Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
|
|
US6093744A
(en)
|
1997-04-21 |
2000-07-25 |
Warner-Lambert Company |
N-acyl sulfamic acid esters useful as hypocholesterolemic agents
|
|
IL121165A0
(en)
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
|
US6004925A
(en)
|
1997-09-29 |
1999-12-21 |
J. L. Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6037323A
(en)
|
1997-09-29 |
2000-03-14 |
Jean-Louis Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
NZ503598A
(en)
|
1997-11-25 |
2002-06-28 |
Warner Lambert Co |
Hydroxylated gemfibrozil, atorvastatin and fluvastatin with antioxidant activity for inhibition of lipoprotein oxidation
|
|
MXPA01009893A
(es)
|
1999-04-01 |
2003-07-28 |
Esperion Therapeutics Inc |
Compuestos con eter, composiciones y usos de estos.
|
|
AU2002211666A1
(en)
|
2000-10-11 |
2002-04-22 |
Esperion Therapeutics, Inc. |
Sulfide and disulfide compounds and compositions for cholesterol management and related uses
|
|
MXPA03003024A
(es)
|
2000-10-11 |
2003-07-14 |
Esperion Therapeutics Inc |
Compuestos de sulfoxido y bis-sulfoxido y composiciones para el control de colesterol y usos relacionados.
|
|
US7304093B2
(en)
|
2000-10-11 |
2007-12-04 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
WO2002030860A2
(en)
|
2000-10-11 |
2002-04-18 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
IL155215A0
(en)
|
2000-10-11 |
2003-11-23 |
Esperion Therapeutics Inc |
Ether compounds and compositions for cholesterol management and related uses
|
|
US7053046B2
(en)
|
2001-12-21 |
2006-05-30 |
Mcgrath Kevin |
Peptide activators of VEGF
|
|
HUE036646T2
(hu)
|
2003-01-23 |
2018-07-30 |
Esperion Therapeutics Inc |
Hidroxilvegyületek és kompozícióik koleszterin szabályozására és kapcsolódó alkalmazásokra
|
|
JP2007525408A
(ja)
|
2003-12-24 |
2007-09-06 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロール管理および関連使用のためのケトン化合物および組成物
|
|
JP4553181B2
(ja)
|
2004-03-25 |
2010-09-29 |
株式会社サタケ |
残留農薬分析方法
|
|
US8209479B2
(en)
|
2007-07-18 |
2012-06-26 |
Google Inc. |
Memory circuit system and method
|
|
US10028926B2
(en)
|
2012-01-06 |
2018-07-24 |
Gemphire Therapeutics Inc. |
Methods of reducing risk of cardiovascular disease
|
|
US9662307B2
(en)
*
|
2013-02-19 |
2017-05-30 |
The Regents Of The University Of Colorado |
Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
|
|
US20160058751A1
(en)
|
2013-03-28 |
2016-03-03 |
Cellworks Group, Inc. |
Composition and method for treating cancer
|
|
WO2015018060A1
(en)
*
|
2013-08-09 |
2015-02-12 |
Agios Pharmaceuticals, Inc. |
Crystalline forms of therapeutically active compounds and use thereof
|
|
RU2022102472A
(ru)
|
2015-03-13 |
2022-03-15 |
Эсперион Терапеутикс, Инк. |
Фиксированные комбинации и составы, содержащие etc-1002 и эзетимиб, и способы лечения или уменьшения риска развития сердечно-сосудистого заболевания
|
|
MA41793A
(fr)
|
2015-03-16 |
2018-01-23 |
Esperion Therapeutics Inc |
Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
|
|
WO2017023165A1
(en)
|
2015-08-04 |
2017-02-09 |
Dezima Pharma B.V. |
Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and an atp citrate lyase inhibitor – ampk activator
|
|
WO2018148417A1
(en)
|
2017-02-08 |
2018-08-16 |
Esperion Therapeutics, Inc. |
Triplet combination formulations and methods of treating or reducing the risk of cardiovascular disease
|
|
TW201906599A
(zh)
|
2017-05-11 |
2019-02-16 |
美商珍費爾醫療公司 |
吉卡賓組成物及其使用方法
|
|
US20180338922A1
(en)
|
2017-05-26 |
2018-11-29 |
Esperion Therapeutics, Inc. |
Fixed dose formulations
|
|
CN107628975B
(zh)
*
|
2017-09-17 |
2019-10-29 |
贵州医科大学 |
赖氨酸衍生物类组蛋白去乙酰化酶抑制剂及其合成和应用
|
|
CN109721486A
(zh)
*
|
2017-10-31 |
2019-05-07 |
鲁南制药集团股份有限公司 |
一种8-羟基-2,2,14,14-四甲基-十五烷二酸的合成方法
|
|
KR20200123181A
(ko)
|
2018-02-16 |
2020-10-28 |
에스페리온 테라피유틱스 인코포레이티드 |
뱀페도익산의 지속 방출형 제제
|
|
EP3666750A1
(en)
*
|
2018-12-10 |
2020-06-17 |
Sandoz AG |
Crystalline form of bempedoic acid
|
|
JP2022516530A
(ja)
*
|
2018-12-31 |
2022-02-28 |
ルピン・リミテッド |
ベンペド酸の新規塩及び多形体
|
|
CN112437766A
(zh)
|
2019-06-21 |
2021-03-02 |
艾斯柏伦治疗公司 |
制备贝派地酸及其组合物的方法
|
|
US12516013B2
(en)
*
|
2019-12-06 |
2026-01-06 |
Synthon B.V. |
Crystalline forms of sodium salt of Bempedoic acid
|
|
WO2022149161A1
(en)
|
2021-01-05 |
2022-07-14 |
Dr. Reddy's Laboratories Limited |
Process for preparation of bempedoic acid and its intermediates
|